ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,182Medicare Part D Prescriptions Filled, Including Refills

Rank: 424 out of 2888

$425K Total Retail Price of All Prescriptions

Rank: 1027 out of 2888

987 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 987 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,875 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 732 653 1 5
CLOPIDOGREL 694 595 2 30
METOPROLOL SUCCINATE 623 565 3 11
FUROSEMIDE 550 490 4 6
PLAVIX 439 386 5 40
SIMVASTATIN 362 335 6 2
METOPROLOL TARTRATE 358 304 7 10
NITROGLYCERIN PATCH 358 340 7 183
ENALAPRIL MALEATE 324 291 9 49
DIGOXIN 316 294 10 55
CARVEDILOL 308 263 11 21
VERAPAMIL ER 308 280 11 104
POTASSIUM CHLORIDE 293 254 13 14
ISOSORBIDE MONONITRATE ER 257 237 14 51
NITROSTAT 189 164 15 240
DILTIAZEM 24HR CD 178 172 16 146
OMEPRAZOLE 175 156 17 7
ATORVASTATIN CALCIUM 171 149 18 9
LEVOTHYROXINE SODIUM 137 127 19 1
MELOXICAM 134 115 20 31
LISINOPRIL 131 131 21 3
AMIODARONE HCL 129 119 22 167
DILTIAZEM HCL 123 121 23 236
ATENOLOL 119 75 24 25
KLOR-CON M10 110 103 25 118
FAMOTIDINE 105 92 26 75
METFORMIN HCL 96 84 27 8
HYDROCHLOROTHIAZIDE 92 82 28 15
KLOR-CON M20 89 87 29 90
LOSARTAN POTASSIUM 82 69 30 18
CLONIDINE HCL 79 55 31 39
BYSTOLIC 78 69 32 99
HYDRALAZINE HCL 77 53 33 59
WARFARIN SODIUM 73 48 34 22
LABETALOL HCL 73 67 34 180
ZOLPIDEM TARTRATE 72 72 36 17
GLYBURIDE 70 63 R 37 58
TRICOR 66 26 38 91
RAMIPRIL 65 58 39 73
DIPYRIDAMOLE 64 64 R 40 378
CRESTOR 59 49 41 20
PRAVASTATIN SODIUM 59 49 41 12
SERTRALINE HCL 59 57 41 27
LIPITOR 57 53 44 78
AZITHROMYCIN 56 43 45 38
NEXIUM 55 53 46 19
ALENDRONATE SODIUM 53 53 47 23
LEVOFLOXACIN 50 48 48 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.